AIM ImmunoTech Participates in Virtual Investor KOL Connect Segment
Provided By GlobeNewswire
Last update: Dec 6, 2024
Segment featuring Dr. Charles Lapp, ME/CFS Key Opinion Leader and founder of the Hunter-Hopkins Center is now available here
Read more at globenewswire.com
